This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundThe incidence and type of complications following catheter ablation of atrialfibrillation have been extensively examined, but the impact associated with these complications on the length of stay and hospitalization costs is unknown.Methods and ResultsThis cohort study included 20 117 adult patients (mean age 62.6±11.4 years,
28, 2025 At theAmerican College of Cardiology (ACC) 2025 meeting,GE HealthCare will introduce RevolutionVibe, i a new computed tomography (CT) system with Unlimited One-Beat Cardiac imaging to deliver consistent, high-quality images for patients, even in challenging cases like atrialfibrillation and heavily calcified coronaries.
In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heart failure, coronary artery disease, vascular disease and atrialfibrillation. Food and Drug Administration authorization.
These measurements can enable the early detection and monitoring of heart rhythm conditions such as atrialfibrillation. and reimbursed using existing reimbursement codes. The FDA-clearance also allows FibriCheck to improve current U.S. business activities. FibriCheck can now be prescribed in the U.S.
This announcement comes at a time when atrialfibrillation (AF) is on the rise, affecting more than 10.5 1 A growing patient population, increase in electrophysiology procedures, and rapid innovation in the field have led to elevated government scrutiny on cost, resulting in drastic cuts for reimbursement for common AF procedures.
Inevitably, given its fledgling status, regulation and reimbursement is still playing catch-up, though 2023 saw some important developments in this regard. Figure 2: VC funding for AI in Medical Imaging vs. ECG The Missing Piece In a similar vein, the reimbursement framework for AI-in ECG is very much in its infancy.
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.
The one-year mortality rates in these groups were 10.57%, 4.21%, and 6.47%, respectively (p = 0.010). In the unadjusted model, the SS group showed a lower risk of one-year mortality [Hazard Ratio (HR) 0.38, 95% CI 0.18–0.80, 0.80, p = 0.011], and the CS group also demonstrated a lower risk (HR 0.59, 95% CI 0.35–0.99,
A recent study published in Nature / Scientific Reports aimed to detect the rate of atrialfibrillation (AF) and further cardiac arrhythmias after acute ischemic stroke. It is also important to mention that throughout Switzerland, care providers are reimbursed for 7-day ECG monitoring. “We It has provided top quality analyses.”
AccurECG provides automated heart rate measurements, supraventricular and ventricular ectopic beat detection, and automated interpretation for 13 different arrhythmias such as atrialfibrillation, atrial flutter, and ventricular tachycardia.
Objective Atrialfibrillation (AF) is a worldwide healthcare challenge owing to population ageing. In this study, we assessed the current trends in the incidence and prevalence of AF for the first time in an unselected, nationwide population. Incident AF was defined as new-onset AF occurring after 2007.
Background Individual variation in the need for healthcare constitutes knowledge gaps for young atrialfibrillation (AF) patients. We aimed to estimate the prevalence and primary care burden of early-onset AF in Norway, emphasising sex differences, in a nationwide healthcare database.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
72 
Let's personalize your content